Literature DB >> 6229807

Interaction of hyperthermia and photoradiation therapy.

S M Waldow, T J Dougherty.   

Abstract

Local microwave hyperthermia (2450 MHz) was applied to axillary implants of the SMT-F mammary carcinoma in mice in combination with photoradiation therapy (PRT) in an attempt to determine if the two modalities interact. When 40.5 degrees C was applied for 30 min immediately prior to or immediately following PRT (630-nm light, 30 min, at 75 mW/cm2, 20-24 hr post 7.5 mg/kg hematoporphyrin derivative), enhancement of tumor response over that of PRT alone was seen as judged by lack of tumor regrowth (35 days or longer after treatment). A temperature of 41.5 degrees C applied for 30 min immediately following the 30-min PRT treatment produced a result slightly greater than that seen at 40.5 degrees C. When a temperature of 44.5 degrees C for 30 min was applied immediately following PRT, a substantial enhancement of tumor control at 35 days post-treatment was found (53% versus 19 and 4%, respectively, for hyperthermia and PRT alone). These results suggest that tumor response to PRT is enhanced by both a sublethal hyperthermic treatment (40.5 degrees C, 41.5 degrees C) and a moderately lethal heat treatment (44.5 degrees C) given for a short duration, when applied immediately before or after photoradiation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6229807

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  8 in total

1.  Increased efficacy of photodynamic therapy of R3230AC mammary adenocarcinoma by intratumoral injection of Photofrin II.

Authors:  S L Gibson; K R van der Meid; R S Murant; R Hilf
Journal:  Br J Cancer       Date:  1990-04       Impact factor: 7.640

2.  Higher irradiance and photodynamic therapy for age-related macular degeneration (an AOS thesis).

Authors:  Joan W Miller
Journal:  Trans Am Ophthalmol Soc       Date:  2008

3.  Photodynamic therapy is potentiated by Co60 and intratumoral injection of hematoporphyrin derivative.

Authors:  H Kostron; M R Swartz; R L Martuza
Journal:  J Neurooncol       Date:  1988-09       Impact factor: 4.130

Review 4.  Current status of photodynamic therapy in oncology.

Authors:  R van Hillegersberg; W J Kort; J H Wilson
Journal:  Drugs       Date:  1994-10       Impact factor: 9.546

5.  Photodynamic therapy effect in an intraocular retinoblastoma-like tumour assessed by an in vivo to in vitro colony forming assay.

Authors:  J Winther
Journal:  Br J Cancer       Date:  1989-06       Impact factor: 7.640

6.  Effects of haematoporphyrin derivative and light in combination with hyperthermia on cells in culture.

Authors:  T Christensen; A Wahl; L Smedshammer
Journal:  Br J Cancer       Date:  1984-07       Impact factor: 7.640

7.  Interstitial photodynamic therapy in a rat liver metastasis model.

Authors:  R van Hillegersberg; J P Marijnissen; W J Kort; P E Zondervan; O T Terpstra; W M Star
Journal:  Br J Cancer       Date:  1992-12       Impact factor: 7.640

8.  Photodynamic therapy of C3H mouse mammary carcinoma with haematoporphyrin di-ethers as sensitizers.

Authors:  J F Evensen; S Sommer; C Rimington; J Moan
Journal:  Br J Cancer       Date:  1987-05       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.